CARA Systems

New York-based health tech company building SaaS for neurovascular conditions with high clinical uncertainty, starting with brain aneurysms — 7 million Americans live with an unruptured aneurysm. Non-invasive, patient-specific risk assessment helps clinicians identify high-risk patients earlier. 2,000+ patient validation with NYU Langone and Bellevue, 93% accuracy for early rupture-risk models, EPIC-approved vendor since August 2026.